EPISODE · Oct 17, 2016 · 16 MIN
CEO Rob Hutchison discusses Target Therapeutic Areas of Focus for biOasis Technologies
from Stock Day Media · host Stock Day Media
Everett Jolly Interviews Rob Hutchison, CEO for biOasis Technologies Inc. (OTC: BIOAF / TSX-V: BTI), and they discuss target therapeutic areas of focus for the company. We are pleased to share the following UPTICK Network Stock Day Radio Show and Podcast content. The CEOs interviewed on Stock Day did not incur any charges for their time with Uptick CEO Everett Jolly. Uptick staff is always looking for exciting companies to bring to our interested readers and listeners. Contact us at (602) 441-3474 if you would like further information on the UPTICK Network or Uptick services. Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
Everett Jolly Interviews Rob Hutchison, CEO for biOasis Technologies Inc. (OTC: BIOAF / TSX-V: BTI), and they discuss target therapeutic areas of focus for the company. We are pleased to share the following UPTICK Network Stock Day Radio Show and Podcast content. The CEOs interviewed on Stock Day did not incur any charges for their time with Uptick CEO Everett Jolly. Uptick staff is always looking for exciting companies to bring to our interested readers and listeners. Contact us at (602) 441-3474 if you would like further information on the UPTICK Network or Uptick services. Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
CEO Rob Hutchison discusses Target Therapeutic Areas of Focus for biOasis Technologies
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m